Symbols / ENVB Stock $5.16 -3.01% Enveric Biosciences, Inc.

Healthcare • Biotechnology • United States • NCM
ENVB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Joseph Edward Tucker Ph.D.
Exch · Country NCM · United States
Market Cap 10.25M
Enterprise Value 5.06M
Income -12.13M
Sales —
FCF (ttm) -4.79M
Book/sh 3.94
Cash/sh 2.48
Employees 5
Insider 10d —
IPO May 04, 2015
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.00
Forward P/E -3.66
PEG —
P/S —
P/B 1.31
P/C —
EV/EBITDA -0.59
EV/Sales —
Quick Ratio 5.09
Current Ratio 5.38
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -36.24
EPS next Y -1.41
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-03-28
Earnings (prior) 2025-03-28
ROA -134.11%
ROE -3.04%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 1.99M
Shs Float 1.85M
Insider Own 3.91%
Instit Own 6.28%
Short Float 3.34%
Short Ratio 2.10
Short Interest 63.02K
52W High 17.84
vs 52W High -71.08%
52W Low 1.71
vs 52W Low 201.75%
Beta 0.33
Impl. Vol. —
Rel Volume 0.14
Avg Volume 4.10M
Volume 592.63K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $5.32
Price $5.16
Change -3.01%
About

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$5.16
Latest analyst target
3. DCF / Fair value
$-43.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.16
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-03-06 reit HC Wainwright & Co. Buy → Buy $10
2024-01-30 init HC Wainwright & Co. — → Buy $10
News
RSS: Latest ENVB news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-23 WEBB MICHAEL D Director — 7,633 $0.00 $0
2025-12-23 PASQUALONE FRANK Director — 7,633 $0.00 $0
2025-12-23 SCHABACKER MARCUS Director — 7,633 $0.00 $0
2025-12-23 KEGLER GEORGE A. JR Director — 7,633 $0.00 $0
2025-12-23 TUCKER JOSEPH EDWARD Chief Executive Officer — 60,296 $0.00 $0
2025-12-23 COVENEY KEVIN MICHAEL Chief Financial Officer — 40,198 $0.00 $0
2025-12-23 DEWITT SHEILA Director — 7,633 $0.00 $0
2025-05-08 TUCKER JOSEPH EDWARD Chief Executive Officer — 98,866 — —
2025-05-08 FACCHINI PETER JAMES Chief Technology Officer — 24,717 — —
2025-05-08 COVENEY KEVIN MICHAEL Chief Financial Officer — 74,150 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Gross Profit
—
—
—
—
Operating Expense
8.77
-8.91%
9.63
-47.36%
18.30
-8.34%
19.96
Research And Development
2.78
-2.12%
2.84
-60.82%
7.25
-9.66%
8.03
Selling General And Administration
5.79
-10.24%
6.45
-39.69%
10.70
-7.80%
11.61
General And Administrative Expense
5.79
-10.24%
6.45
-39.69%
10.70
-7.80%
11.61
Other Gand A
5.79
-10.24%
6.45
-27.10%
8.85
-23.73%
11.61
Total Expenses
8.77
-8.91%
9.63
-47.36%
18.30
-8.34%
19.96
Operating Income
-8.77
+8.91%
-9.63
+47.36%
-18.30
+8.34%
-19.96
Total Operating Income As Reported
-8.77
+8.91%
-9.63
+41.44%
-16.45
+40.00%
-27.42
EBITDA
-8.57
+7.76%
-9.29
+48.04%
-17.89
+8.34%
-19.52
Normalized EBITDA
-8.57
+7.76%
-9.29
+50.87%
-18.92
+3.11%
-19.53
Reconciled Depreciation
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
EBIT
-8.77
+8.91%
-9.63
+47.36%
-18.30
+8.30%
-19.95
Total Unusual Items
—
0.05
-95.54%
1.03
+10976.86%
0.01
Total Unusual Items Excluding Goodwill
—
0.05
-95.54%
1.03
+10976.86%
0.01
Special Income Charges
—
—
0.00
+100.00%
-7.45
Impairment Of Capital Assets
—
—
0.00
-100.00%
7.45
Net Income
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Pretax Income
-8.77
+8.30%
-9.57
+44.59%
-17.26
+13.50%
-19.96
Net Non Operating Interest Income Expense
-0.00
-148.40%
0.00
-94.09%
0.00
+170.64%
-0.01
Interest Expense Non Operating
—
—
—
0.01
Net Interest Income
-0.00
-148.40%
0.00
-94.09%
0.00
+170.64%
-0.01
Interest Expense
—
—
—
0.01
Interest Income Non Operating
—
0.00
-94.09%
0.00
—
Interest Income
—
0.00
-94.09%
0.00
—
Other Income Expense
0.00
-96.11%
0.07
-93.59%
1.03
+10976.86%
0.01
Other Non Operating Income Expenses
0.00
-96.11%
0.07
—
—
Gain On Sale Of Security
—
0.05
-95.54%
1.03
-86.20%
7.46
Tax Provision
0.00
-100.00%
0.01
-69.11%
0.03
+101.95%
-1.49
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+182.02%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.22
+31139.45%
0.00
Net Income Including Noncontrolling Interests
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Net Income From Continuing Operation Net Minority Interest
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Net Income From Continuing And Discontinued Operation
-8.77
+8.39%
-9.57
+44.69%
-17.31
+6.45%
-18.50
Net Income Continuous Operations
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Minority Interests
—
0.00
+100.00%
-0.02
+42.32%
-0.03
Normalized Income
-8.77
+8.39%
-9.57
+47.17%
-18.12
+2.10%
-18.51
Net Income Common Stockholders
-12.13
-26.70%
-9.57
+45.16%
-17.46
+7.14%
-18.80
Otherunder Preferred Stock Dividend
3.36
0.00
—
—
Diluted EPS
-36.24
+84.14%
-228.48
+84.30%
-1,455.48
-646.40%
-195.00
Basic EPS
-36.24
+84.14%
-228.48
+84.30%
-1,455.48
-646.40%
-195.00
Basic Average Shares
0.33
-33.44%
0.50
+249.39%
0.14
+49.31%
0.10
Diluted Average Shares
0.33
-33.44%
0.50
+249.39%
0.14
+49.31%
0.10
Diluted NI Availto Com Stockholders
-12.13
-26.70%
-9.57
+45.16%
-17.46
+7.14%
-18.80
Depreciation Amortization Depletion Income Statement
0.20
-40.48%
0.34
-1.89%
0.34
+4.90%
0.33
Depreciation And Amortization In Income Statement
0.20
-40.48%
0.34
-1.89%
0.34
+4.90%
0.33
Preferred Stock Dividends
—
—
0.15
-50.00%
0.30
Rent And Landing Fees
—
0.00
-100.00%
1.85
0.00
Rent Expense Supplemental
—
0.00
-100.00%
1.85
0.00
Total Other Finance Cost
0.00
+148.40%
-0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.10
+65.32%
3.08
-28.31%
4.30
-78.01%
19.55
Current Assets
4.94
+80.53%
2.73
-23.65%
3.58
-80.57%
18.43
Cash Cash Equivalents And Short Term Investments
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Cash And Cash Equivalents
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Cash Financial
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Receivables
—
0.00
-100.00%
0.22
0.00
Taxes Receivable
—
0.00
-100.00%
0.22
0.00
Prepaid Assets
0.22
-56.24%
0.49
-1.55%
0.50
-29.19%
0.71
Current Deferred Assets
0.04
0.00
-100.00%
0.57
0.00
Other Current Assets
—
—
—
0.71
Total Non Current Assets
0.16
-54.24%
0.35
-51.56%
0.72
-35.92%
1.12
Net PPE
0.16
-47.92%
0.31
-39.73%
0.51
-31.56%
0.74
Gross PPE
0.83
+4.98%
0.80
-8.08%
0.87
-5.98%
0.92
Accumulated Depreciation
-0.68
-38.04%
-0.49
-36.81%
-0.36
-100.09%
-0.18
Machinery Furniture Equipment
0.03
+5.03%
0.03
-8.13%
0.03
+12.90%
0.03
Other Properties
0.81
+4.98%
0.77
-8.08%
0.84
-6.51%
0.89
Goodwill And Other Intangible Assets
0.00
-100.00%
0.04
-80.00%
0.21
-44.45%
0.38
Goodwill
—
—
—
0.00
Other Intangible Assets
—
—
—
0.38
Total Liabilities Net Minority Interest
0.92
-38.35%
1.49
-36.43%
2.34
-41.35%
4.00
Current Liabilities
0.92
-38.35%
1.49
-36.43%
2.34
-41.35%
4.00
Payables And Accrued Expenses
0.92
-38.35%
1.49
-35.07%
2.29
+5.79%
2.17
Payables
0.77
-24.51%
1.02
-18.16%
1.24
+167.90%
0.46
Accounts Payable
0.58
+11.36%
0.52
-57.19%
1.22
+163.08%
0.46
Other Payable
—
0.02
—
—
Current Accrued Expenses
0.15
-68.01%
0.47
-55.00%
1.05
-38.25%
1.71
Total Tax Payable
0.09
-67.11%
0.26
+1069.91%
0.02
0.00
Current Debt And Capital Lease Obligation
—
—
—
0.06
Current Capital Lease Obligation
—
—
0.00
-100.00%
0.06
Other Current Liabilities
—
0.00
-93.71%
0.05
-97.22%
1.76
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
0.00
Long Term Debt And Capital Lease Obligation
—
—
—
0.00
Long Term Capital Lease Obligation
—
—
—
0.00
Non Current Deferred Liabilities
—
—
—
0.00
Non Current Deferred Taxes Liabilities
—
—
—
0.00
Preferred Securities Outside Stock Equity
0.00
0.00
0.00
0.00
Stockholders Equity
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Common Stock Equity
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Capital Stock
0.01
+1778.76%
0.00
-69.07%
0.00
-91.21%
0.02
Common Stock
0.01
+1778.76%
0.00
-69.07%
0.00
-91.21%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1.06
+56.57%
0.68
+271.26%
0.18
+31.81%
0.14
Ordinary Shares Number
1.06
+56.57%
0.68
+271.26%
0.18
+31.81%
0.14
Additional Paid In Capital
119.59
+10.47%
108.26
+7.36%
100.84
+6.83%
94.40
Retained Earnings
-114.85
-8.27%
-106.07
-9.92%
-96.50
-21.83%
-79.21
Gains Losses Not Affecting Retained Earnings
-0.58
+2.44%
-0.59
-4.35%
-0.57
-6.15%
-0.54
Minority Interest
—
0.00
0.00
-100.00%
0.89
Other Equity Adjustments
-0.58
+2.44%
-0.59
-4.35%
-0.57
-6.15%
-0.54
Total Equity Gross Minority Interest
4.18
+162.28%
1.59
-18.58%
1.96
-87.42%
15.56
Total Capitalization
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Working Capital
4.02
+222.79%
1.24
+0.55%
1.24
-91.42%
14.44
Invested Capital
4.18
+162.28%
1.59
-18.58%
1.96
-86.67%
14.67
Total Debt
—
—
0.00
-100.00%
0.06
Capital Lease Obligations
—
—
0.00
-100.00%
0.06
Net Tangible Assets
4.18
+169.41%
1.55
-11.16%
1.75
-87.79%
14.29
Tangible Book Value
4.18
+169.41%
1.55
-11.16%
1.75
-87.79%
14.29
Derivative Product Liabilities
—
—
—
—
Dueto Related Parties Current
0.10
-57.12%
0.23
0.00
—
Other Equity Interest
—
—
-1.82
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.14
-5.38%
-7.73
+45.18%
-14.09
+17.80%
-17.15
Cash Flow From Continuing Operating Activities
-8.14
-5.38%
-7.73
+45.18%
-14.09
+17.80%
-17.15
Net Income From Continuing Operations
-8.77
+8.39%
-9.57
+44.63%
-17.29
+6.39%
-18.47
Depreciation Amortization Depletion
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
Depreciation
0.16
-5.96%
0.17
-29.48%
0.24
-10.20%
0.27
Amortization Cash Flow
0.04
-75.00%
0.17
0.00%
0.17
+0.00%
0.17
Depreciation And Amortization
0.20
-40.48%
0.34
-17.29%
0.41
-6.24%
0.44
Amortization Of Intangibles
0.04
-75.00%
0.17
0.00%
0.17
+0.00%
0.17
Other Non Cash Items
-0.10
-123.73%
0.42
-77.37%
1.85
—
Stock Based Compensation
0.83
-47.05%
1.56
-27.34%
2.15
-17.95%
2.62
Asset Impairment Charge
—
—
0.00
-100.00%
7.45
Deferred Tax
—
—
0.00
+100.00%
-1.50
Deferred Income Tax
—
—
0.00
+100.00%
-1.50
Operating Gains Losses
-0.00
+94.42%
-0.05
+95.55%
-1.03
+86.14%
-7.46
Gain Loss On Investment Securities
-0.00
+94.42%
-0.05
+95.54%
-1.03
+86.20%
-7.46
Gain Loss On Sale Of PPE
—
0.00
+100.00%
-0.00
0.00
Change In Working Capital
-0.30
+30.08%
-0.42
-142.20%
-0.17
+19.71%
-0.22
Change In Prepaid Assets
0.25
+40.58%
0.18
+2703.12%
-0.01
+98.17%
-0.37
Change In Payables And Accrued Expense
-0.55
+9.12%
-0.60
-479.44%
-0.10
-139.38%
0.26
Change In Payable
-0.55
+9.12%
-0.60
-479.44%
-0.10
—
Change In Account Payable
-0.41
+50.41%
-0.83
-703.70%
-0.10
—
Change In Other Working Capital
—
—
-0.06
+40.31%
-0.11
Change In Other Current Liabilities
—
—
—
-0.11
Investing Cash Flow
—
0.00
-100.00%
0.01
+102.00%
-0.58
Cash Flow From Continuing Investing Activities
—
0.00
-100.00%
0.01
+102.00%
-0.58
Net PPE Purchase And Sale
—
0.00
-100.00%
0.01
+102.00%
-0.58
Purchase Of PPE
—
0.00
+100.00%
-0.01
+99.11%
-0.58
Sale Of PPE
—
0.00
-100.00%
0.02
0.00
Capital Expenditure
—
—
-0.01
+99.11%
-0.58
Net Business Purchase And Sale
—
—
—
0.00
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Financing Cash Flow
10.58
+37.86%
7.67
+671.33%
-1.34
-107.39%
18.18
Cash Flow From Continuing Financing Activities
10.58
+37.86%
7.67
+671.33%
-1.34
-107.39%
18.18
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Repurchase Of Capital Stock
—
0.00
+100.00%
-1.05
0.00
Proceeds From Stock Option Exercised
4.70
+4.83%
4.48
0.00
0.00
Net Other Financing Charges
—
-0.18
+37.52%
-0.29
-130.38%
0.96
Changes In Cash
2.44
+4761.05%
-0.05
+99.66%
-15.43
-3533.70%
0.45
Effect Of Exchange Rate Changes
-0.00
-128.00%
0.01
+153.42%
-0.01
+87.68%
-0.08
Beginning Cash Position
2.24
-2.05%
2.29
-87.09%
17.72
+2.12%
17.36
End Cash Position
4.68
+108.72%
2.24
-2.05%
2.29
-87.09%
17.72
Free Cash Flow
-8.14
-5.38%
-7.73
+45.20%
-14.10
+20.48%
-17.73
Interest Paid Supplemental Data
0.00
0.00
0.00
-100.00%
0.01
Income Tax Paid Supplemental Data
0.00
-100.00%
0.01
-47.41%
0.01
0.00
Common Stock Issuance
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Issuance Of Capital Stock
5.88
+74.32%
3.37
0.00
-100.00%
17.22
Net Preferred Stock Issuance
—
0.00
+100.00%
-1.05
0.00
Preferred Stock Payments
—
0.00
+100.00%
-1.05
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category